Stutzmann J M, Cepeda C, Naquet R
Exp Neurol. 1984 Nov;86(2):379-87. doi: 10.1016/0014-4886(84)90194-8.
Suriclone (SC) is a new anxiolytic compound with a chemical structure different from that of benzodiazepines (BZD) but SC possesses a high affinity for the so-called BZD receptors. SC was tested in the naturally or the allylglycine-treated photosensitive baboon Papio papio. As active BZD administered by the intramuscular or oral route, this new compound possesses a marked protective effect against the excessive photosensitivity of the baboons, it blocks myoclonus following EEG spike and waves discharges induced by intermittent light stimulation; as BZD again, SC can induce spontaneous myoclonus not accompanied by EEG spike and wave discharges.
舒立克隆(SC)是一种新型抗焦虑化合物,其化学结构与苯二氮䓬类(BZD)不同,但SC对所谓的BZD受体具有高亲和力。在自然状态下或经烯丙基甘氨酸处理的光敏狒狒(豚尾狒狒)身上对SC进行了测试。作为通过肌肉注射或口服途径给药的活性BZD,这种新化合物对狒狒的过度光敏性具有显著的保护作用,它能阻断由间歇性光刺激诱发的脑电图尖波和慢波放电后的肌阵挛;同样作为BZD,SC可诱发不伴有脑电图尖波和慢波放电的自发性肌阵挛。